These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


282 related items for PubMed ID: 25994014

  • 1. Pharmacotherapy for inherited arrhythmia syndromes: mechanistic basis, clinical trial evidence and practical application.
    Tadros R, Cadrin-Tourigny J, Abadir S, Rivard L, Nattel S, Talajic M, Khairy P.
    Expert Rev Cardiovasc Ther; 2015; 13(7):769-82. PubMed ID: 25994014
    [Abstract] [Full Text] [Related]

  • 2. Pharmacotherapy in inherited and acquired ventricular arrhythmia in structurally normal adult hearts.
    Ortmans S, Daval C, Aguilar M, Compagno P, Cadrin-Tourigny J, Dyrda K, Rivard L, Tadros R.
    Expert Opin Pharmacother; 2019 Dec; 20(17):2101-2114. PubMed ID: 31566420
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Amplification of spatial dispersion of repolarization underlies sudden cardiac death associated with catecholaminergic polymorphic VT, long QT, short QT and Brugada syndromes.
    Antzelevitch C, Oliva A.
    J Intern Med; 2006 Jan; 259(1):48-58. PubMed ID: 16336513
    [Abstract] [Full Text] [Related]

  • 5. Atrial fibrillation in inherited cardiac channelopathies: From mechanisms to management.
    Enriquez A, Antzelevitch C, Bismah V, Baranchuk A.
    Heart Rhythm; 2016 Sep; 13(9):1878-84. PubMed ID: 27291509
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Drug-induced fatal arrhythmias: Acquired long QT and Brugada syndromes.
    Turker I, Ai T, Itoh H, Horie M.
    Pharmacol Ther; 2017 Aug; 176():48-59. PubMed ID: 28527921
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Inherited cardiac arrhythmia syndromes: what have they taught us about arrhythmias and anti-arrhythmic therapy?
    Subbiah RN, Campbell TJ, Vandenberg JI.
    Clin Exp Pharmacol Physiol; 2004 Dec; 31(12):906-12. PubMed ID: 15659058
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Diagnosis and management of patients with inherited arrhythmia syndromes in Europe: results of the European Heart Rhythm Association Survey.
    Hocini M, Pison L, Proclemer A, Larsen TB, Madrid A, Blomström-Lundqvist C, Scientific Initiative Committee, European Heart Rhythm Association.
    Europace; 2014 Apr; 16(4):600-3. PubMed ID: 24711616
    [Abstract] [Full Text] [Related]

  • 15. [Genetic arrhythmias and gender].
    Biernacka EK.
    Przegl Lek; 2014 Apr; 71(3):139-41. PubMed ID: 25154209
    [Abstract] [Full Text] [Related]

  • 16. Role of pharmacotherapy in cardiac ion channelopathies.
    El-Sherif N, Boutjdir M.
    Pharmacol Ther; 2015 Nov; 155():132-42. PubMed ID: 26376080
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Active cascade screening in primary inherited arrhythmia syndromes: does it lead to prophylactic treatment?
    Hofman N, Tan HL, Alders M, van Langen IM, Wilde AA.
    J Am Coll Cardiol; 2010 Jun 08; 55(23):2570-6. PubMed ID: 20513597
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 15.